    Latest News             TOPICS                                                                                                           Latest              News                           FOR IMMEDIATE RELEASE  December 8  2005 Schumer Praises Roche Agreements With 2 Major U S  Generic Drug Companies To Increase Supply Of Tamiflu To Help Stockpile Against Potential Avian Flu Pandemic                                                                                                                                                                                                                                                   Roche Expected to Announce Agreements with 15 Drug Manufacturers to License Parts of Production for Tamiflu  the Most Effective Treatment Against a Possible Avian Flu Pandemic   Schumer    The Administration and Congress Must Provide Funding for Those Stockpiles Immediately Now that Roche Has Stepped Up and Made Significant Progress Towards Increasing Tamiflu Production   Today  Sen  Chuck Schumer announced that Roche Pharmaceuticals has reached agreements with major domestic generic drug companies Teva Pharmaceuticals and Mylan Laboratories  as well as 13 other drug producers  to dramatically increase the supply of Tamiflu  the leading remedy for Avian flu that is currently available  On October 20  2005  Senators Schumer and Lindsey Graham announced that Roche Pharmaceuticals was committed to meeting with four generic drug companies to redouble their efforts to vastly increase supply of their Avian flu treatment by licensing production to more drug companies  Earlier this year  Roche  the maker of Tamiflu  worked collaboratively with Schumer to figure out ways to dramatically increase production of their treatment Avian Flu       Roche has made the right decision  Instead of closely holding their patent rights and production techniques  in the face of a global health risk  they  ve moved swiftly to partner with multiple companies to dramatically increase production of this potentially life saving drug     Schumer said     Schumer stated    The Administration and Congress must provide funding for those stockpiles immediately now that Roche has stepped up and made significant progress towards increasing Tamiflu production         These agreements that Roche has reached are still dependent on orders placed for Tamiflu by governments around the world  and funding for those orders from the U S  government and other countries that want to increase their stockpiles of treatment for a possible Avian flu pandemic      In October  Schumer provided the names of four companies to Mr  George Abercrombie  the CEO of Roche in the United States  Roche has reached agreements with two of those companies along with 13 other entities around the world  Roche agreed in October to sub license the production of Tamiflu to any of these companies that can produce it in quantities large enough to help meet the anticipated demand in case of a flu outbreak  and the determination as to who gets licensed will be made in cooperation with the U S  Government and other governments around the world      Tamiflu is the only known effective treatment for avian flu  and Roche holds the exclusive rights to manufacturing it  One company simply cannot handle all the demand when tens and hundreds of millions of doses are being ordered  Roche will continue working with these companies until the bottleneck of supply for government stockpiling purposes has been relieved  at which point they may regain their status as sole manufacturer  The purpose here is not to break the patent on Tamiflu  but rather to meet an emergency need for quantities of this drug that Roche itself simply cannot do alone                                                                              